Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016
IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
TNF-α, IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic Source: Annual Congress 2013 –Asthma Year: 2013
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015
Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011
IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012